# Tricaprilin in Mild to Moderate Alzheimer's Disease

> **NCT00142805** · PHASE2 · COMPLETED · sponsor: **Cerecin** · enrollment: 152 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Tricaprilin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00142805
- **Lead sponsor:** Cerecin
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11-04
- **Primary completion:** 2006-06-29
- **Final completion:** 2007-01-07
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2020-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00142805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00142805, "Tricaprilin in Mild to Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00142805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*